Background. The purpose of this study was to investigate the effects of halothane and sevoflurane on the magnitude of the increase in intracellular calcium with hypoxia in carotid body type I (glomus) cells. We wished to ascertain if the effects of these agents in single cells paralleled their known effects on the human hypoxic ventilatory response, where halothane depresses this response more than does sevoflurane.
It is well established that even at low concentrations of $0.1 minimum alveolar concentration (MAC), volatile anaesthetics depress the human ventilatory response to hypoxia by 50-70%. 1 At .1 MAC, the hypoxic response is virtually abolished. 2 -4 However, different agents appear to depress the hypoxic ventilatory response to different degrees. Halothane is the most depressive, diminishing the hypoxic response by $50% at 0.1 MAC. 1 2 5 6 Sevoflurane is one of the least depressive, obtunding the response by just $20% at the same concentration. 1 7 8 Volatile agents have also been found to depress chemoreflex responses in intact animals, 9 -13 but an important limitation of much whole animal work is that integrity of all elements of the respiratory control system makes it difficult to establish whether the primary effect of anaesthetic occurs at the peripheral chemoreceptors or at some central point in the chemoreflex loop. Also, possible differential effects of the agents on ventilatory control have not been fully explored in animals. A recent review of the literature on animal studies whose methodology had functionally isolated the carotid body concluded that volatile anaesthetics do indeed depress carotid body response to hypoxia. 14 This review was, however, unable to confirm the notion-raised by the human work referred to above-that the carotid body was differently sensitive to various agents.
Developments in our understanding of mechanisms of oxygen sensing in the carotid body, and the potential for anaesthetics to interact with these mechanisms, offer an opportunity to re-examine this question from a fresh perspective. 15 -20 For example, Buckler and colleagues 15 described a background TASK-like K þ channel in the carotid body glomus (type I) cell that is sensitive to hypoxia, acid, and halothane. Background K þ channels are important in determining resting membrane potential, and the reduction of their open probability by hypoxia (and acid or CO 2 ) results in depolarization of the cell 16 and voltage-gated Ca 2þ influx. 17 If this channel responds similarly with other volatile anaesthetics, it would make a compelling case that it underlies the mechanisms involved in the effect of all volatile anaesthetics on the human chemoreflex response.
Regardless of the specific molecular mechanisms involved in oxygen-or anaesthetic-sensing at the carotid body, it is important first to establish if an anaesthetic depresses glomus cell hypoxic response and further, if the variation in anaesthetic effect known in humans is reflected in a similar variation in effect at the glomus cell.
The aim of this study, therefore, was to investigate the effect of the agents halothane and sevoflurane on the response of the carotid body glomus cell to hypoxia (measured by the magnitude increase in intracellular calcium concentration, [Ca 2þ ] i with hypoxia-the 'Ca 2þ transient'). We chose halothane and sevoflurane to approximate to the known 'extremes' of response. The former is arguably the most depressive in humans 1 2 5 6 and (notwithstanding one report that desflurane depresses the acute hypoxic response in humans very little) 21 the latter is consistently shown by a number of reports as being one of the least depressive. 1 7 8 22 We wished to establish 'dose -response' relationships for their effects. If the glomus cells were sensitive to volatile anaesthetics, we would expect both halothane and sevoflurane to depress the hypoxia-induced Ca 2þ transient. Furthermore, if the glomus cells were differentially sensitive to the two agents in a manner similar to the human ventilatory response, we would expect that halothane would depress the hypoxiainduced Ca 2þ transient more than would sevoflurane.
Methods

Cell isolation
Experiments were performed on glomus cells enzymatically isolated from neonatal Sprague -Dawley rat pups (10 -13 days old), as described elsewhere. 15 23 24 Briefly, rat pups were anaesthetized using halothane 4% in O 2 and the carotid bodies excised and placed in ice-cold saline (the rats were then killed by decapitation, in accord with United Kingdom Home Office animal licence procedures and supervised by the Committee on Animal Care and Ethical Review, University of Oxford). The carotid bodies were incubated in a phosphate-buffered saline containing collagenase (0.5 mg ml 21 , Type 1, Worthington, Freehold, NJ, USA) and trypsin (0.2 mg ml
21
, Sigma-Aldrich, St Louis, MO, USA) at 378C and then mechanically dispersed by the use of forceps followed by trituration through fire-polished glass pipettes. The cell suspension was then centrifuged, resuspended in culture medium (Ham's F-12 supplemented with 10% v/v heat-inactivated fetal calf serum, 100 IU ml 21 penicillin, 100 mg ml 21 streptomycin, and 84 unit litre 21 insulin), and plated out onto glass coverslips coated with poly-D-lysine (SigmaAldrich). Cells were maintained in culture medium for 2-4 h at 358C in CO 2 5% in air until use. The time difference between anaesthesia and experimentation was at least 4 h, more than sufficient for any halothane acting on the cells at the time of animal preparation to have completely dissipated.
Microspectrofluorimetry
A microspectrofluorimeter was constructed from an inverted microscope (Nikon Diaphot, Nikon, Tokyo, Japan). 23 24 The fluorescence-excitation light source was provided by a 100 W xenon lamp. Fluorescent emissions were detected by a pair of tri-alkali photomultiplier tubes (PMT; EMI 9658R) cooled to between approximately 217 and 2208C. The output from each PMT was fed through a current-to-voltage converter and then digitized (250 Hz; CED 1401) and stored on the hard disk of a computer. The collected data from each PMT were integrated over 500 ms intervals, ratioed, and calibrated as described below.
Measurement of intracellular calcium
Cells were loaded with indo-1 by incubation with 2.5 mM indo 1-AM (the acetoxymethyl ester form) in culture medium at room temperature (20 -248C) for 1 h (indo 1-AM was added from a 1 mM stock solution in dimethyl sulphoxide). Indo-1 fluorescence was excited at 340 (SD 5) nm and measured at 405 (16) and 495 (10) nm (using PMTs). [Ca 2þ ] was calculated with the following equation: 
Gas control
Euoxic solutions were made by equilibrating the above Tyrode with CO 2 5% in air, and hypoxic solutions by equilibrating Tyrode with CO 2 5% in N 2 95%. After gas equilibration, pH was 7.4-7.45 at 358C for both euoxic and hypoxic solutions. The hypoxic solutions yield a hypoxic stimulus of $0.26 kPa (measured in the perfusion chamber), which has been shown to approximate the microvascular PO 2 in the carotid body in intact animals when the end-tidal or arterial PO 2 is $6.6 kPa (a dose commonly used in human studies). 25 -27 This level of hypoxia also achieves robust cell excitation to help differentiate between anaesthetic agents that weakly and strongly inhibit the glomus cell (i.e. the 'weaker' agents might otherwise obtund feeble cell excitation with a gentler hypoxic stimulus, but are less likely to counteract robust cell excitation).
In a manner previously confirmed to yield solution concentrations to within 90% of vaporizer settings 28 within 5 min of bubbling, anaesthetic was administered by equilibrating Tyrode with halothane or sevoflurane via calibrated vaporizers (the equilibration period was at least 45 min). The output of each vaporizer was checked for each vaporizer dial setting for a range of gas flow rates over a sustained period of use using a Datex-Ohmeda Capnomac Ultima gas analyzer (Datex-Ohmeda, Madison, WI, USA) itself calibrated with a standard gas. While the MAC of halothane in humans is $0.8% 29 and the MAC of sevoflurane $2.2%, 30 rat values are somewhat different, at 1.1% and 2.5% respectively. 31 
32
Protocols
The prepared coverslips containing the cells were transferred to a perfusion chamber of $100 ml volume, mounted on the stage of the inverted Nikon Diaphot microscope (described above). Solutions were delivered from gas-impermeable glass bottles at 35-378C under gravity via medical grade stainless steel tubing (also gas impermeable) to a low-volume tap and from there via a very short length (5 cm) of low gas permeability narrow bore (1/32 in.), thick walled (3/32 in.) Pharmed tubing (Saint-Gobain Glass, London, UK) to the experimental chamber. The volume of the experimental chamber was ,100 ml, solution flow rate was $4 ml min 21 resulting in a solution exchange half-time of ,2 s.
Solutions were either Tyrode equilibrated with CO 2 5% in air ('euoxia') or Tyrode equilibrated with hypoxic gas ('hypoxia'). Both euoxic and hypoxic Tyrode were equilibrated with anaesthetic for the protocols described below. We have previously confirmed that, when using Tyrode bubbled with nitrogen, there is little leak of oxygen into the perfusate along the length of this apparatus (i.e. the PO 2 achieved in the cell perfusion chamber was found to be ,0.26 kPa). 33 Consequently, there is unlikely to be any significant leak of anaesthetic out of solution along the length of our apparatus, consistent with previous reports of the impermeability of the tubing we used. Each experimental period consisted of the cells being exposed to the following steps: first at least 90 s exposure to euoxia; then $90 s exposure to hypoxia (a shorter exposure was used if the cells demonstrated a decline with time in the magnitude of the Ca 2þ transient with sustained hypoxia); then at least 120 s period of equilibration with euoxia plus anaesthetic; then a $90 s exposure to hypoxia plus anaesthetic; then at least 90 s washout with euoxia; and finally a $90 s exposure to hypoxia.
We also conducted experiments to assess anaesthetic influence on the increase in [Ca 2þ ] i in response to 100 mM K þ . All experiments were conducted with background euoxic gas, with or without anaesthetic. Each experimental period consisted of the following steps: first at least 90 s exposure to standard Tyrode; then a $30 s exposure to high-K þ Tyrode; then at least 120 s exposure to standard Tyrode equilibrated with anaesthetic; then a $30 s exposure to high-K þ Tyrode equilibrated with anaesthetic; then at least 90 s washout with standard Tyrode; and finally a $30 s exposure to high-K þ Tyrode. The anaesthetics used for this part of the experiment were either halothane 2% (1.81 MAC) or sevoflurane 5% (2 MAC represented the anaesthetic effect. Thus, the ratio would be 1.0 if anaesthetic had no effect; if anaesthetic abolished the response to hypoxia completely, the ratio would be zero.
We used the same process of analysis for the control data in Ca 2þ -free solution. We averaged the ratios obtained at each concentration of anaesthetic to obtain the mean for that concentration, separately for each of the two agents. The statistical significance of differences between the means of the ratios was assessed using factorial analysis of variance (ANOVA, SPSS for Windows version 10.0, SPSS Inc., Chicago, IL, USA). The ratio of the Ca 2þ transient was the 'response', and there were two repeated measures factors: 'agent' (two levels, one for each of the agents, halothane and sevoflurane) and 'concentration' (four levels, one for each of the concentrations used in each agent). The locations of any significant effects were explored using post hoc Student's t-tests with Bonferroni's correction applied at the appropriate level to adjust for multiple comparisons.
We analysed the responses to 100 mM K þ in a similar manner. For each exposure to 100 mM K represented the anaesthetic effect. Thus, the ratio would be 1.0 if anaesthetic had no effect; if anaesthetic abolished the response to 100 mM K þ completely, the ratio would be zero. We assessed the statistical significance of differences between the means of the two agents, and between the means of each agent vs control using Student's t-tests. Figure 1 shows the results of a typical experimental period using halothane. [Ca 2þ ] i increased rapidly on induction of hypoxia, this response being attenuated in a dose-related manner by halothane (Fig. 1) . The magnitude of the Ca 2þ response to hypoxia after anaesthetic washout was similar to that before any anaesthetic administration. Figure 2 shows the patterns of responses were similar in the protocols using sevoflurane, but this agent seemed to attenuate the hypoxic response somewhat less than did halothane at an equivalent concentration. Figure 3A shows the ranges of absolute [Ca 2þ ] i values for the six test conditions. The baseline euoxic and peak values in hypoxia are consistent with measurements of previous reports in these cell preparations.
Results
15-19 23 24 39 -41
In the absence of background anaesthetic, there was an approximately nine-fold range (1.2 -11.2) in the increase in [Ca 2þ ] i from baseline (mean 3.2-fold, SD 2.2, interquartile range 1.8 -3.5-fold) as is typical for this cell preparation 15-19 23 24 39-42 and paralleling approximately eight-fold ranges (mean 3 -4-fold) reported in the human hypoxic ventilatory response. 43 44 Figure 3B also indicates the range of values for Ca 2þ transient for control and each of the four concentrations of halothane and sevoflurane, respectively, and demonstrates the dramatic effect of halothane upon this increase, which contrasts with the more modest effect of sevoflurane. Figure 4 shows the effect of the two anaesthetics on this response to hypoxia, plotted as a 'dose -response' relationship normalized to the mean control value. The relationship for halothane appeared generally steeper than that for sevoflurane. ANOVA confirmed significant effects of both 'agent' P,0.001 (n¼76, d.f. 1) and 'concentration' P,0.001 (n¼76, d.f. 3), indicating that both agents depressed the hypoxic response and that this effect was dependent on their concentration. In the ANOVA, the interaction of 'agent' and 'concentration' was also significant (P¼0.036; n¼76, d.f. 3), indicating that the effect of concentration varied with the agent used, that is, that halothane caused more profound depression of Ca 2þ response with concentration than did sevoflurane (Fig. 1) . Post hoc t-tests with the Bonferroni correction confirmed that the effect of halothane was depressive at all concentrations (e.g. P¼0.001 at 0.2%; n¼8), but the depressive Anaesthetics and glomus cell response to hypoxia effect of sevoflurane was only significant at the highest concentration (P¼0.001 at 5%; n¼7). Figure 5 shows results from the control Ca 2þ -free experiment. Cells that demonstrated a large response to hypoxia in standard Tyrode showed no convincing response to hypoxia in Ca 2þ -free solution. Figure 6 shows the range of 
Discussion
Our main result that halothane and sevoflurane both significantly depress the type I cell Ca 2þ response to hypoxia is probably the first demonstration that volatile anaesthetics can attenuate glomus cell activity. These effects on the hypoxic response vary with concentration for both agents and these effects on hypoxic response and high K þ response differ for the two agents, with halothane attenuating the responses more than sevoflurane. Our observations in single cells are consistent with previous reports on the Pandit and Buckler effects of these agents on respiratory chemoreflexes in animals 14 and in humans. 1 -8 We find remarkable similarities between the effect of the two anaesthetics in humans and single cells. At a concentration of 0.1-0.2 MAC, halothane reduces human hypoxic ventilatory response by $50%, 1 2 5 6 a value similar to the reduction in [Ca 2þ ] i transient response at $0.2 MAC (Fig. 4) . At a concentration of 0.1-0.2 MAC, sevoflurane reduces human hypoxic ventilatory response by $20%, 1 7 8 22 a value almost identical to the reduction in [Ca 2þ ] i response at $0.2 MAC (Fig. 4) . Higher concentrations (.1 MAC) of halothane virtually abolish the human hypoxic ventilatory response, 2 and this is also consistent with the single cell response (Fig. 4) . Sjögren and colleagues 45 reported that in contrast to halothane, highdose sevoflurane (0.8 MAC in background poikilocapnia) does not abolish the human acute hypoxic ventilatory response. Again this seems consistent with the persistence of the [Ca 2þ ] i response in our study at the higher doses of sevoflurane (Fig. 4) . All this makes it very tempting to conclude that the anaesthetic effects on type I cell activity that we report underlie their effects on whole-body hypoxic ventilatory response (i.e. the primary site of action of anaesthetic when depressing the hypoxic response in humans is at the carotid body). Although this conclusion does not preclude an additional anaesthetic effect on the chemoreflex arc more centrally in the brain, it does make such an action somewhat redundant. If anaesthetics inhibit the response to hypoxia at carotid body level, then little or no information can travel along the afferent pathway to the brain.
Molecular basis of anaesthetic action
It is pertinent to make some comment on possible molecular mechanisms of the effects we describe. Halothane, as previously reported, may exert its effect via the hypoxiaacid -anaesthetic-sensitive TASK-like K þ channel, 15 and this may be the case also for sevoflurane. If so, then one implication of our result is that the affinity, the efficacy, or both of these two agents differ for this channel. Our results justify the need to assess this possibility more directly using voltage-clamp techniques. Indeed, an investigation of any such differential effects of anaesthetics may also be helpful in determining which two-pore K þ channel subtypes constitute the TASK-like channels in glomus cells. For example, it is well known that TREK-1 and TASK channels can be differentiated on the basis of (among other things) their sensitivity to halothane (which activates TASK-1, TASK-3, and TREK-1) and chloroform and diethyl ether (which only activate TREK-1). 46 47 A recent report indicated that halothane, sevoflurane, and isoflurane all open human TASK-1 channels expressed in oocytes (and that this response differs from the i.v. agents propofol and etomidate), but dose-related effects between the volatile agents were not examined. 48 In a preliminary report, Cotten and Miller 49 observed that 1 MAC of agent potentiated the TASK-3 mediated current in Fisher rat thyroid epithelial monolayer preparations in the order halothane.enflurane.desflurane.nitrous oxide. They correctly noted that this was also the order of potency of these agents in depressing the human hypoxic ventilatory response. 1 Our results help bridge the gap between these anaesthetic effects on channels from non-respiratory tissue, and show similar differential effects on the glomus cell response, indicating that the channel effects could plausibly explain whole-body ventilatory effects.
We discovered that both halothane and sevoflurane also reduce the [ Values for both agents differ from unity (P,0.001), and the value for halothane differs from that for sevoflurane (*P¼0.004).
voltage-gated Ca 2þ channels, 52 53 (ii) any calcium-induced calcium release from the endoplasmic reticulum ( probably a minor component), 54 (iii) cytosolic Ca 2þ buffering ( probably a fixed factor), 51 (iv) mitochondrial Ca 2þ buffering, 40 and (v) plasma membrane Ca 2þ extrusion ( probably occurring via a Ca 2þ ATPase pump). 55 Our finding therefore indicates that halothane, and to a lesser extent sevoflurane, must also interfere with at least some of these signalling processes in glomus cells. Further studies are needed to locate the precise site of action, but there is evidence that voltage-gated Ca 2þ channels are inhibited by anaesthetic agents in neural 56 and cardiac 57 tissue, although little is currently known about their interaction with anaesthetics in the carotid body. We also noted that although both agents depressed the Ca 2þ response to high K þ , they did so to different degrees, with halothane being the more depressive (Fig. 7) . If components of the hypoxic transduction mechanism other than the TASK-like channel are also susceptible to anaesthetics, then such 'dual' site of action may help explain how the hypoxic chemoreflex is so exquisitely sensitive to these agents: a combination of activation of background K þ channels with inhibition of voltage-gated Ca 2þ channels should profoundly depress glomus cell activity.
The glomus cell is a useful model for investigating mechanisms of anaesthetic action. Although much of the work on anaesthetic-channel interaction has been described for neuronal channels, 46 47 these results cannot be easily extrapolated to predicting whole-body responses. In other words, if a certain novel drug influences a neuronal K þ channel in a manner similar to that of known anaesthetics, it does not necessarily mean that this novel drug will have anaesthetic properties. The carotid body is different: for all agents that reduce glomus cell [Ca 2þ ] i response to hypoxia, we can be absolutely certain that (toxicity apart) they will depress the organism's ventilatory response to hypoxia. This very direct link between molecular/cellular physiology and phenotype can be exploited to gain important insights into both anaesthetic action and channel function.
Conclusions
In summary, we describe the direct, depressive influences of volatile anaesthetic agents on glomus cell responses to hypoxia. We further report that agents can differ in their effects on this response. The results we obtain are remarkably similar to those in humans and so suggest that these cellular responses underlie the whole-body ventilatory response.
It would be desirable for future studies to extend our observations to acid or carbon dioxide stimuli and to investigate the effect of other anaesthetics (e.g. isoflurane) and also i.v. agents (e.g. propofol) on glomus cell responses. Jonsson and colleagues 58 found that propofol antagonized both hypoxia-and nicotine-induced increases in afferent carotid sinus nerve activity in an isolated carotid body preparation, suggesting that this drug acts at the synapse to prevent acetylcholine released from carotid body cells binding with nicotinic receptors of the afferent glossopharyngeal nerve terminal. Our cell preparation could be used to test the alternative hypothesis that propofol exerts an inhibitory action directly on the glomus cell, in a manner similar to volatile anaesthetics that we describe here. It would further be important to establish if the effects we describe for volatile anaesthetics are mediated by differential sensitivity of the hypoxia-and anaesthetic sensitive TASK-like K þ channel to various agents, or if other mechanisms (such as voltage-gated Ca 2þ channels) are more important.
